Chemoinformatics and chemical genomics: potential utility ofin silicomethods-Reference-Cited by-同舟云学术

Chemoinformatics and chemical genomics: potential utility ofin silicomethods

Published:2012-08-10 Issue:11 Volume:32 Page:880-889
ISSN:0260-437X
Container-title:Journal of Applied Toxicology
language:en
Short-container-title:J. Appl. Toxicol.

Author:

Valerio Luis G.¹,Choudhuri Supratim²

Affiliation:

1. Science and Research Staff, Office of Pharmaceutical Science, Center for Drug Evaluation and Research; US Food and Drug Administration; White Oak 51, Room 4128, 10903 New Hampshire Avenue; Silver Spring; MD; 20993-0002; USA

2. Division of Biotechnology and GRAS Notice Review, Office of Food Additive Safety, Center for Food Safety and Applied Nutrition; US Food and Drug Administration; White Oak 51, Room 4128, 10903 New Hampshire Avenue; Silver Spring; MD; 20993-0002; USA

Publisher

Wiley

Subject

Toxicology

Reference85 articles.

1. Feature selection for structure-activity correlation using binary particle swarms;Agrafiotis;J. Med. Chem.,2002

2. Recent advances in chemoinformatics;Agrafiotis;J. Chem. Inf. Model.,2007

3. Applications of rule-induction in the derivation of quantitative structure-activity relationships;Al-Razzak;J. Comput. Aided Mol. Des.,1992

4. Regulatory use of computational toxicology tools and databases at the United States food and drug administration's office of food additive safety;Arvidson;Expert Opin. Drug Metab. Toxicol.,2010

5. Neural networks in building QSAR models;Baskin;Meth. Mol. Biol.,2008

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding and targeting resistance mechanisms in cancer;MedComm;2023-05-22

2. Cofactor-Receptor Interaction-Based Pharmacophore Design for Development of Novel Inhibitors: A Case Study Against Tuberculosis;Drugs and a Methodological Compendium;2023

3. In silico studies on recreational drugs: 3D quantitative structure activity relationship prediction of classified and de novo designer benzodiazepines;Chemical Biology & Drug Design;2022-09-05

4. Designer Benzodiazepines’ Activity on Opioid Receptors: A Docking Study;Current Pharmaceutical Design;2022-09

5. Designer Benzodiazepines' Activity on Opioid Receptors: A Docking Study;CURR PHARM DESIGN;2022